Form 8-K - Current report:
SEC Accession No. 0001193125-18-166310
Filing Date
2018-05-17
Accepted
2018-05-17 13:13:32
Documents
2
Period of Report
2018-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d590870d8k.htm 8-K 17068
2 EX-10.1 d590870dex101.htm EX-10.1 7148
  Complete submission text file 0001193125-18-166310.txt   25314
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 18842402
SIC: 3841 Surgical & Medical Instruments & Apparatus